Torley Helen

Halozyme Therapeutics, Inc. · PRESIDENT AND CEO

Torley Helen serves as the President and CEO of Halozyme Therapeutics, Inc., a company focused on advancing innovative therapies for patients with unmet medical needs. Under her leadership, Halozyme has made significant strides in the healthcare sector, particularly in developing drug delivery technologies. Between May 13, 2026, and July 9, 2026, she reported 20 disclosures, all related to sale activity, with amounts ranging from $83.0K to $23.2K. The most notable transaction occurred on June 3, 2026, when she sold shares valued at approximately $1.1 million.

History Trades

CompanyValueActionPriceLast Price
Halozyme Therapeutics, Inc.HALO$425k6.1k sharesSellJun 3, 2026$69.69$77.54
Halozyme Therapeutics, Inc.HALO$137k2k sharesSellJun 3, 2026$68.74$77.54
Halozyme Therapeutics, Inc.HALO$102k1.5k sharesSellJun 3, 2026$67.68$77.54
Halozyme Therapeutics, Inc.HALO$27k400 sharesSellJun 3, 2026$66.37$77.54
Halozyme Therapeutics, Inc.HALO$1M16.6k sharesSellJun 2, 2026$66.31$77.54
Halozyme Therapeutics, Inc.HALO$227k3.4k sharesSellJun 2, 2026$66.75$77.54
Halozyme Therapeutics, Inc.HALO$876k13k sharesSellJun 1, 2026$67.41$77.54
Halozyme Therapeutics, Inc.HALO$369k5.4k sharesSellJun 1, 2026$68.35$77.54
Halozyme Therapeutics, Inc.HALO$107k1.6k sharesSellJun 1, 2026$66.39$77.54
Halozyme Therapeutics, Inc.HALO$276k4k sharesSellMay 13, 2026$69.79$77.54
Halozyme Therapeutics, Inc.HALO$231k3.4k sharesSellMay 13, 2026$68.88$77.54
Halozyme Therapeutics, Inc.HALO$143k2.1k sharesSellMay 13, 2026$68.10$77.54
Halozyme Therapeutics, Inc.HALO$42k600 sharesSellMay 13, 2026$70.81$77.54
Halozyme Therapeutics, Inc.HALO$700k9.8k sharesSellMay 12, 2026$71.37$77.54
Halozyme Therapeutics, Inc.HALO$426k5.9k sharesSellMay 12, 2026$72.15$77.54
Halozyme Therapeutics, Inc.HALO$205k2.8k sharesSellMay 12, 2026$73.12$77.54
Halozyme Therapeutics, Inc.HALO$98k1.4k sharesSellMay 12, 2026$70.29$77.54
Halozyme Therapeutics, Inc.HALO$6.8k100 sharesSellMay 12, 2026$67.85$77.54
Halozyme Therapeutics, Inc.HALO$629k9.7k sharesSellMay 11, 2026$64.63$77.54
Halozyme Therapeutics, Inc.HALO$444k6.7k sharesSellMay 11, 2026$66.33$77.54
Halozyme Therapeutics, Inc.HALO$234k3.6k sharesSellMay 11, 2026$65.46$77.54
Halozyme Therapeutics, Inc.HALO$373k5.9k sharesSellApr 6, 2026$63.14$77.54
Halozyme Therapeutics, Inc.HALO$262k4.1k sharesSellApr 6, 2026$64.02$77.54
Halozyme Therapeutics, Inc.HALO$1M15.8k sharesSellApr 2, 2026$64.06$77.54
Halozyme Therapeutics, Inc.HALO$273k4.2k sharesSellApr 2, 2026$64.89$77.54
Halozyme Therapeutics, Inc.HALO$1M19k sharesSellApr 1, 2026$65.36$77.54
Halozyme Therapeutics, Inc.HALO$66k1k sharesSellApr 1, 2026$65.71$77.54
Halozyme Therapeutics, Inc.HALO$513k7.3k sharesSellMar 4, 2026$69.94$77.54
Halozyme Therapeutics, Inc.HALO$189k2.7k sharesSellMar 4, 2026$70.95$77.54
Halozyme Therapeutics, Inc.HALO$928k13.5k sharesSellMar 3, 2026$68.85$77.54
Halozyme Therapeutics, Inc.HALO$452k6.5k sharesSellMar 3, 2026$69.33$77.54
Halozyme Therapeutics, Inc.HALO$1M15.3k sharesSellMar 2, 2026$69.80$77.54
Halozyme Therapeutics, Inc.HALO$284k4.1k sharesSellMar 2, 2026$69.20$77.54
Halozyme Therapeutics, Inc.HALO$41k578 sharesSellMar 2, 2026$70.46$77.54
Halozyme Therapeutics, Inc.HALO$421k5.4k sharesSellFeb 5, 2026$78.38$77.54
Halozyme Therapeutics, Inc.HALO$365k4.6k sharesSellFeb 5, 2026$78.94$77.54
Halozyme Therapeutics, Inc.HALO$783k10.1k sharesSellFeb 4, 2026$77.54$77.54
Halozyme Therapeutics, Inc.HALO$762k9.9k sharesSellFeb 4, 2026$76.94$77.54
Halozyme Therapeutics, Inc.HALO$734k9.7k sharesSellFeb 3, 2026$75.94$77.54
Halozyme Therapeutics, Inc.HALO$598k7.8k sharesSellFeb 3, 2026$76.73$77.54
Halozyme Therapeutics, Inc.HALO$191k2.6k sharesSellFeb 3, 2026$74.88$77.54
Halozyme Therapeutics, Inc.HALO$713k10.4k sharesSellDec 1, 2025$68.51$77.54
Halozyme Therapeutics, Inc.HALO$375k5.4k sharesSellDec 1, 2025$69.44$77.54
Halozyme Therapeutics, Inc.HALO$35k500 sharesSellDec 1, 2025$70.36$77.54
Halozyme Therapeutics, Inc.HALO$19k261 sharesSellDec 1, 2025$71.60$77.54